China Merchants Bank (03968) nominated Wang Xiaoqing as an executive director.

China Merchants Bank (03968) announced that on May 28, 2026, China Merchants Bank Limited ("the Company") held the sixteenth meeting of the thirteenth Board of Directors (the Board Meeting) and approved the proposal to nominate Mr. Li Yungui as a non-executive director and Mr. Huoda as a non-executive director. The Board agreed to nominate Mr. Li Yungui and Mr. Huoda as candidates for non-executive directors of the thirteenth Board of Directors of the Company, subject to approval at the shareholders' meeting. After approval at the shareholders' meeting, Mr. Li Yungui and Mr. Huoda's qualifications for directorship will be subject to review by the China Banking and Insurance Regulatory Commission, with the term of office starting from the date of approval by the China Banking and Insurance Regulatory Commission until the expiration of the thirteenth Board of Directors. At the Board Meeting, the Board also approved the proposal to nominate Mr. Wang Xiaoqing as an executive director. The Board agreed to nominate Mr. Wang Xiaoqing as a candidate for an executive director of the thirteenth Board of Directors of the Company, subject to approval at the shareholders' meeting. After approval at the shareholders' meeting, Mr. Wang Xiaoqing's qualifications for directorship will be subject to review by the China Banking and Insurance Regulatory Commission, with the term of office starting from the date of approval by the China Banking and Insurance Regulatory Commission until the expiration of the thirteenth Board of Directors. At the Board Meeting, the Board also approved the proposal to nominate Mr. Zhang Yong as independent director 1. The Board agreed to nominate Mr. Zhang Yong as a candidate for an independent director of the thirteenth Board of Directors of the Company, subject to approval at the shareholders' meeting. After approval at the shareholders' meeting, Mr. Zhang Yong's qualifications for independent directorship will be subject to review by the China Banking and Insurance Regulatory Commission, with the term of office starting from the date of approval by the China Banking and Insurance Regulatory Commission until the expiration of the thirteenth Board of Directors.